Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Monthly doctor visits could speed up shoulder pain relief

NCT ID NCT06517680

Symptom relief Sponsor: Nantes University Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares two ways of managing rotator cuff tendinopathy, a common cause of shoulder pain. One group gets monthly check-ups for three months with treatment adjustments as needed, while the other follows standard care. Researchers want to see if the tighter follow-up leads to faster improvement and less chronic pain. The trial involves 156 adults aged 18-65 with new-onset shoulder pain.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
tight control management (monthly consultations with treatment adjustments including steroid injections, drugs, and physiotherapy)
What this could lead to
If successful, this approach could provide a more effective way to manage early rotator cuff pain, reducing chronicity and healthcare costs.
What could go wrong
This is a small, early-phase trial with only 156 participants. The tight management may not prove significantly better than standard care, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 156 people

The number the study aims to enrol. It can still change while the study runs.

Started

Nov 2024

Expected to finish

Nov 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria : Patient with new-onset shoulder pain related to rotator cuff tendinopathy * Age between 18 and 65 * Shoulder pain on activity for less than 6 months with VAS≥4/10 and/or OSS≥20 * Pain compatible with rotator cuff tendinopathy according to the rotator cuff tendinopathy according to the BESS (British Elbow and Shoulder Society) guidelines Exclusion Criteria: * Contraindication to steroid injections * Shoulder pain related to trauma (dislocation, fracture) or acute tendon rupture requiring short-term surgery * Steroid injection already performed on the shoulder studied for the current episode * Neurological pathology affecting the shoulder * Other shoulder disorders (inflammatory arthritis, frozen shoulder, glenohumeral joint instability, pain associated with acromioclavicular arthropathy) * Tendon calcification \> 0.5 cm. * Previous shoulder surgery * Full-thickness tear of one tendon * Pregnant women

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Rotator cuff tendinopathy are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

disease of the tendon rotator cuff syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Rotator cuff tendinopathy

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    8 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • CH Cholet

    RECRUITING

    Cholet, 49325, France

  • CH Vendée

    RECRUITING

    La Roche-sur-Yon, 85925, France

  • CH du Mans

    RECRUITING

    Le Mans, 72037, France

  • CHRU de Tours

    RECRUITING

    Chambray-lès-Tours, 37170, France

  • CHU Angers

    RECRUITING

    Angers, 49033, France

  • CHU de Brest

    RECRUITING

    Brest, 29200, France

  • CHU de Nantes

    RECRUITING

    Nantes, 44093, France

  • Chotard Emilie

    RECRUITING

    Rennes, 35203, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.